NewAmsterdam Pharma Company NV (NASDAQ: NAMS) is 80.13% higher on its value in year-to-date trading and has touched a low of $8.90 and a high of $26.35 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NAMS stock was last observed hovering at around $20.01 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $20.12, the stock is -5.99% and 5.99% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.06 million and changing 0.55% at the moment leaves the stock 3.24% off its SMA200. NAMS registered 101.60% gain for a year compared to 6-month gain of 5.34%. The firm has a 50-day simple moving average (SMA 50) of $18.9012 and a 200-day simple moving average (SMA200) of $19.490175.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 4.25% loss in the last 1 month and extending the period to 3 months gives it a 23.74%, and is -19.42% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.34% over the week and 6.51% over the month.
Distance from 52-week low is 126.07% and -23.64% from its 52-week high.
The EPS is expected to grow by 4.36% this year
123.0 institutions hold shares in NewAmsterdam Pharma Company NV (NAMS), with institutional investors hold 89.77% of the company’s shares. The shares outstanding are 82.47M, and float is at 42.87M with Short Float at 1.67%. Institutions hold 89.54% of the Float.
NewAmsterdam Pharma Company NV (NAMS) Insider Activity
The most recent transaction is an insider sale by ForGrowth NAP B.V., the company’s 10% Owner. SEC filings show that ForGrowth NAP B.V. sold 33,273 shares of the company’s common stock on Nov 18 ’24 at a price of $25.08 per share for a total of $0.83 million. Following the sale, the insider now owns 11.78 million shares.
NewAmsterdam Pharma Company NV disclosed in a document filed with the SEC on Nov 15 ’24 that ForGrowth NAP B.V. (10% Owner) sold a total of 8,530 shares of the company’s common stock. The trade occurred on Nov 15 ’24 and was made at $25.02 per share for $0.21 million. Following the transaction, the insider now directly holds 11.81 million shares of the NAMS stock.
Still, SEC filings show that on Nov 14 ’24, ForGrowth NAP B.V. (10% Owner) disposed off 9,832 shares at an average price of $25.01 for $0.25 million. The insider now directly holds 11,820,563 shares of NewAmsterdam Pharma Company NV (NAMS).
